期刊文献+

布洛芬与人血白蛋白位点Ⅱ动态结合过程的分子模拟:一种结合途径分析 被引量:1

Molecular Simulations on Dynamic Binding of Ibuprofen onto Site Ⅱ of Human Serum Albumin:One Potential Way Analysis
下载PDF
导出
摘要 人血白蛋白(HSA)主要有两个药物结合位点,位点I和位点II,许多小分子优先结合在位点II上,包括抗炎类药物布洛芬。本文采用分子模拟方法研究了布洛芬小分子与HSA位点II结合的动态过程,探讨了二者的结合机制。首先构建了50个随机分布的布洛芬与HSA复合物体系,经50 ns分子动力学模拟,其中一个布洛芬分子稳定结合于位点II。基于该分子的运动轨迹分析,发现布洛芬的结合可分为四个阶段,即远程吸引、表面结合调整、进入位点II空腔和稳定结合。比较范德华和静电相互作用能,发现初期以静电吸引为主,中期在HSA表面的两个极性区域间调整,逐步转移至位点II附近;然后在位点II入口处的极性残基和附近疏水残基的共同作用下,布洛芬进入位点II空腔;进入空腔后,静电和疏水共同作用形成稳定结合。在结合过程中,位点II附近的蛋白表面发生明显改变,体现出一定的"诱导契合"作用,同时分子模拟得到的结合模式和布洛芬-HSA结合的晶体结构类似。结果表明,分子模拟可以辅助研究小分子和蛋白结合的动态过程,从分子水平阐述相关结合机制。 Human serum albumin (HSA) has two main drug binding sites termed Site I and Site Ⅱ. Most small molecules like ibuprofen (a well-known anti-inflammatory drug) bind to Site Ⅱ preferentially. In this study, molecular simulation methods were used to investigate the dynamic binding process of ibuprofen to Site Ⅱ. A system of 50 ibuprofen molecules distributed randomly around HSA was constructed. After a 50-ns molecular dynamics simulation, one ibuprofen molecule bound stably to Site Ⅱ. Based on trajectory analysis of this ibuprofen molecule, the binding process of ibuprofen onto SiteⅡ can be divided into four phases: (i) long-range attraction; (ii) adjustment on the surface; (iii) entering to Site II pocket; and (iv) stable binding at Site I1. After evaluating van der Waals' and electrostatic interaction energies during the binding process, it was found that the initial major driving force involves electrostatic attractions. Subsequently, ibuprofen locks between two polar regions on the surface near Site Ⅱ and then moves to Site Ⅱ Ibuprofen then enters the pocket of Site II by combinatorial effects of polar and hydrophobic residues nearby the entrance of Site Ⅱ. Electrostatic and hydrophobic interactions form the stable binding of ibuprofen in Site Ⅱ. The molecular surface near Site Ⅱ was observed to change significantly during binding, which indicates an induced fit mechanism. The binding mode obtained with molecular simulations is consistent with the crystal structure of the ibuprofen-HSA complex. The results show that molecular simulations would help to evaluate the dynamic binding processes of small molecules to proteins and improve our understanding of the binding mechanisms at the molecular level.
出处 《物理化学学报》 SCIE CAS CSCD 北大核心 2016年第11期2811-2818,共8页 Acta Physico-Chimica Sinica
基金 国家自然科学基金(21476198,21276228,21576233)资助项目~~
关键词 人血白蛋白 位点Ⅱ 布洛芬 动态结合 分子模拟 Human serum albumin Site II Ibuprofen Dynamic binding Molecular simulation
  • 相关文献

参考文献25

  • 1Sudlow, G.; Birkett, D. J.; Wade, D. N. Mol. Pharmacol. 1975, 11 (6): 824.
  • 2He, X. M.; Carter, D. C. Nature 1992, 358 (6683): 209. doi: 10.1038/358209a0.
  • 3Ghuman, J.; Zunszain, P. A.; Petitpas, I.; Bhattacharya, A. A.; Otagiri, M.; Curry, S. J. Mol. Biol. 2005, 353 (1): 38. doi: 10.1016(j.jmb.2005.07.075.
  • 4Bradley, J. D.; Brandt, K. D.; Katz, B. P.; Kalasinski, L. A.; Ryan, S. I. NewEngl. J. Med. 1991, 325 (2): 87. doi: 10.1056/ NEJM 199107113250203.
  • 5徐诗文,林东强,姚善泾.人血白蛋白结合位点II的分子结合模式研究[J].物理化学学报,2016,32(7):1819-1828. 被引量:3
  • 6Gustafsson, S. S.; Vrang, L.; Terelius, Y.; Danielson, U. H. Anal. Biochem. 2011, 409 (2): 163. doi: 10.1016/j.ab.2010.10.028.
  • 7Yang, F.; Zhang, Y.; Liang, H. Int. J. Mol. Sci. 2014, 15 (3): 3580. doi: 10.3390/ijms15033580.
  • 8Varshney, A.; Sen, P.; Ahmad, E.; Rehan, M.; Subbarao, N.; Khan, R. H. Chiralitv 2010, 22 (1): 77. doi: 10.1002/chir.20709.
  • 9Aghaee, E.; Ghasemi, J. B.; Manouchehri, F.; Balalaie, S. 2014, 20 (10): 1. doi: 10.1007/s00894-014-2446-7.
  • 10郭清莲,潘凌立,杨立云,何欢,张业中,刘义.吡虫啉与人血清白蛋白相互作用热力学行为[J].物理化学学报,2016,32(1):274-282. 被引量:6

二级参考文献97

  • 1刘春莉,李春华,陈慰祖,王存新.用分子模拟方法研究HIV-1整合酶与咖啡酰基类抑制剂的相互作用[J].物理化学学报,2005,21(11):1229-1234. 被引量:9
  • 2Ueno, H.; Suzuki, T.; Kinosita, K.; Yoshida, M. Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 1333. doi: 10.1073/pnas.0407857102.
  • 3(a) Mitchell, P. Nature 1961, 191, 144. doi: 10.1038/191144a0.
  • 4Rastogi, V. K.; Girvin, M. E. Nature 1999, 402, 263.
  • 5(a) Abrahams, J. P.; Leslie, A.; Lutter, R.; Walker, J. E. Nature 1994, 370, 621. doi: 10.1038/370621a0.
  • 6Zhou, Y.; Duncan, T. M.; Cross, R. L. Proc. Natl. Acad. Sci. U. S. A. 1997, 94, 10583.
  • 7Okuno, D.; Iino, R.; Noji, H. J. Biochem. 2011, 149, 655.
  • 8Iino, R.; Hasegawa, R.; Tabata, K. V.; Noji, H. J. Biol. Chem. 2009, 284, 17457.
  • 9Al-Shawi, M. K.; Nakamoto, R. K. Biochemistry 1997, 36, 12954. doi: 10.1021/bi971477z.
  • 10Masaike, T.; Mitome, N.; Noji, H.; Muneyuki, E.; Yasuda, R.; Kinosita, K.; Yoshida, M. J. Exp. Biol. 2000, 203, 1.

共引文献8

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部